相关实验视频

Updated: May 24, 2025

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

美国越南退伍军人同时患有淋巴细胞恶性瘤的治疗和生存

Matthew R Moldenhauer¹, Pankaj Gupta², Helen Ma^2,3,4

¹Department of Medicine, University of California San Diego, La Jolla, CA 92093, USA.

Military medicine

|March 4, 2025

概括

暴露于色剂并没有增加越南退伍军人同时出现淋巴细胞恶性瘤的风险. 多种淋巴细胞癌的诊断没有显著影响存活率,为退伍军人咨询和政策提供了信息.

科学领域:

血液学血液学血液学
毒理学毒理学毒理学
流行病学流行病学

背景情况:

军方接触有毒物质,包括剂,是淋巴细胞恶性瘤的潜在危险因素.
同时的淋巴细胞恶性瘤可以表现为复合性,不和性或转变的淋巴瘤.

研究的目的:

在越南退伍军人中调查 Agent Orange 暴露与并发性淋巴细胞恶性瘤之间的关联.
为了比较患有并发性淋巴细胞恶性瘤和单一淋巴细胞恶性瘤的患者的生存结果.

主要方法:

使用国家VA中央癌症登记处进行的回顾性病例控制研究.
确定了并发性淋巴细胞恶性瘤的病例,并将其与单个淋巴细胞恶性瘤的对照组进行了比较.
检查了与色剂暴露的关联.

主要成果:

同时的淋巴细胞恶性瘤很少见 (0.4%),常见的组合包括慢性淋巴细胞白血病 (CLL) 和扩散大B细胞淋巴瘤.
色剂暴露与并发性淋巴细胞恶性瘤的风险增加无关.
患有并发性和单一淋巴细胞恶性瘤的患者之间的生存率没有显著差异.

结论:

在这个队列中,色剂暴露似乎没有影响并发性淋巴细胞恶性瘤的发展.
同时发生的淋巴细胞恶性瘤并没有显著影响患者的存活率.
调查结果将有助于为退伍军人提供咨询,并为有关毒性物质暴露和癌症的政策制定提供信息.

更多相关视频

Surgical Treatment of an Endolymphatic Sac Tumor

Surgical Treatment of an Endolymphatic Sac Tumor

Published on: May 26, 2023

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma

Published on: January 25, 2015

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...